Sequentially immune-induced antibodies could cross-neutralize SARS-CoV-2 variants.

Qi LvShasha ZhouFeifei QiYaqing ZhangFengdi LiMingya LiuLinlin Bao

Published in: Animal models and experimental medicine (2022)

This study demonstrated that despite a reduction in neutralization titers, cross-neutralizing activity against Omicron and Delta variants was still observed after three doses of inactivated and recombinant protein vaccination.

Keyphrases

sars cov
copy number
diabetic rats
high glucose
respiratory syndrome coronavirus
drug induced
gene expression
amino acid
cell free
protein protein
binding protein
coronavirus disease
genome wide